Document Detail


Priapism in sickle-cell disease: a hematologist's perspective.
MedLine Citation:
PMID:  21554552     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Priapism is a familiar problem to hematologists, well known for its association with sickle-cell disease (SCD). It also occurs in a variety of other hematological illnesses, nearly all forms of congenital hemolytic anemia, including other hemoglobinopathies and red blood cell membranopathies and enzymopathies.
AIM: Provide urologists with a comprehensive review of priapism in SCD, with an emphasis on the perspective of a practicing hematologist.
METHODS: Medline searches through July 2010 were conducted using the terms priapism, erectile dysfunction, and sickle cell.
MAIN OUTCOME MEASURES: Expert opinion was based on review of the medical literature related to this subject matter.
RESULTS: In men with SCD, large epidemiological studies have linked the risk of priapism to clinical markers of the severity of intravascular hemolysis. Extracellular hemoglobin and arginase released during hemolysis has been implicated in reducing nitric oxide bioavailability, although the relevance of hemolysis to vascular dysfunction has been challenged by some scientists. Consistent with the role of impairment of the nitric oxide axis, mice genetically deficient in nitric oxide production have also been shown to develop priapic activity. Provocative new data indicate that hemolysis-linked dysregulation of adenosine signaling in the penis contributes to priapism in sickle cell mice. Serious questions have arisen regarding the efficacy of mainstays of textbook dogma for treatment of acute severe priapism, including intravenous fluids, alkalinization, and exchange transfusion, and there is increasing acceptance for early aspiration and irrigation of the corpus cavernosum.
CONCLUSION: For patients with sickle cell with recurrent priapism, there is very limited evidence for a medical prophylaxis role for hydroxyurea, etilefrine, pseudoephedrine, leuprolide, sildenafil, and other agents. Recent publications have highlighted nitric oxide and adenosine signal transduction pathways as worthy of additional research. Research and clinical management of sickle-cell priapism is strengthened by multidisciplinary collaboration between hematologists and urologists.
Authors:
Gregory J Kato
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Review     Date:  2011-05-06
Journal Detail:
Title:  The journal of sexual medicine     Volume:  9     ISSN:  1743-6109     ISO Abbreviation:  J Sex Med     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-01-06     Completed Date:  2012-05-07     Revised Date:  2013-06-30    
Medline Journal Info:
Nlm Unique ID:  101230693     Medline TA:  J Sex Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  70-8     Citation Subset:  IM    
Copyright Information:
© 2011 International Society for Sexual Medicine.
Affiliation:
National Heart, Lung and Blood Institute, National Institutes of Health-Sickle Cell Vascular Disease Section, Cardiovascular and Pulmonary Branch, Bethesda, MD 20892-1476, USA. gkato@mail.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia, Sickle Cell / blood,  complications*
Hemoglobin, Sickle / metabolism
Hemolysis / physiology
Humans
Male
Nitric Oxide / deficiency
Priapism / blood,  etiology*,  therapy
Risk Factors
Grant Support
ID/Acronym/Agency:
ZIA HL006014-01/HL/NHLBI NIH HHS; ZIA HL006014-02/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Hemoglobin, Sickle; 10102-43-9/Nitric Oxide
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Imbalanced Low-Grade Inflammation and Endothelial Activation in Patients with Type 2 Diabetes Mellit...
Next Document:  New Insights into the Pathophysiology of Sickle Cell Disease-Associated Priapism.